Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study35

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study21

Views

Views
November 20240
December 20240
January 20251
February 20250
March 202516
April 20252
May 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Argentina1
Spain1
United Kingdom1
Hong Kong1
United States1
 

Top cities views

Views
Council Bluffs1
Hong Kong1
Monte Grande1